DREAMS illuminates spatial DNA and RNA modification landscapes

In plain English

The team adapted mass-spectrometry imaging to measure modified nucleic-acid building blocks directly across tissue sections. They applied the method to mouse brains lacking TET enzymes, then compared the spatial chemical maps with transcriptomic changes.

What they found

• TET loss altered broad spatial modification landscapes.
• TET1-dependent changes in RNA m1A correlated with transcriptome changes.

The catch

• The free modified-nucleoside pool is a proxy and does not identify the exact DNA or RNA molecule carrying each modification.
• The mechanistic result comes from mouse genetic models and requires validation in other systems.

Methods at a glance

Study type

Peer-reviewed research article

Biological system

TET-deficient mouse brain tissue

Organism

TET-deficient mouse brain tissue

Dataset

Spatial mass-spectrometry imaging and matched transcriptomic analyses

Sample size

Not reported

Model architecture

DNA RNA Elements Areal Mass Spectrometry (DREAMS)

Training objective

Not applicable or not specified in the abstract-level source basis

Code

No standalone code release was identified in the abstract-level review.

Data

Source data are linked from the open article.

Tasks and metrics

Tasks: spatial modification mapping; TET-dependent comparison

Metrics: Study-specific experimental and computational measures reported in the article

Baselines: Comparators described by the authors in the published article

Principal findings

• TET1 loss was associated with spatial RNA m1A changes and transcriptome differences

What remains unresolved

External validation: Not reported

• The free modified-nucleoside pool is a proxy and does not identify the exact DNA or RNA molecule carrying each modification.
• The mechanistic result comes from mouse genetic models and requires validation in other systems.